Analysis of out-of-pocket health expenditures in South Korea reveals that the expenditure expressed in units of GDP saw a general upward trend from 2013 to 2023, peaking at 2.48 in 2028. Specifically, the data shows a stable increment with minor fluctuations over the years. The Compound Annual Growth Rate (CAGR) from 2013 to 2023 averaged around 1.64%, indicating a steady growth pattern. Recent years saw a stabilization trend, with only a slight increase from 2.46 in 2022 to 2.47 in 2023, marking a marginal year-on-year variation of 0.16%. The forecasted data from 2024 to 2028 indicates minimal change, with a forecasted 5-year CAGR of just 0.06%.
Future trends to watch for include:
- A potential stabilization in out-of-pocket expenditures relative to GDP, suggesting a plateau in growth.
- Impact of potential policy changes aimed at reducing personal healthcare costs.
- Technological advancements and telemedicine that could influence the cost dynamics.
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...